🗞️ GDMT is associated with reduced loop diuretic requirements, whereas diuretic dose does not modify GDMT benefit in heart failure: #STRONG_HF@GiuseppeGalati_@AmrAbdin10@HanCardiomd
https://t.co/NRWhI3cUku
🫀 The second universal definition of heart failure (2026): what's new?💡3 LVEF groups instead of 4, with no fixed cut-offs 💡First universal classification of HF aetiology (18 groups)💡Clear split between worsening HF and decompensated HF 💡Normal NPs should not end the HFpEF workup Viewpoint #ESCHeartFailure, open access 👇 https://t.co/drPmaxZQsH
#HeartFailure #CardioTwitter
@EJHFEiC@AmrAbdin10@GiuseppeGalati_@HanCardiomd@EJHFEiC@JanBiegus@ppponikowski #HFA_ESC @hvanspall@FudimMarat@gcfmd@MarcoMetra@GianluSava
⏳ DEADLINES EXTENDED | #CVCT2026
More time to bring your research to Washington, D.C.
🔬 Late-Breaking Clinical Trials
NEW deadline: October 8
📊 Poster Presentations
NEW deadline: October 15
Submit: https://t.co/NhFw9qcA6H
#CVCT#LBCT#Posters
LAST CALL | CVCT-LMIC Fellowship
Join the global clinical trials community at #CVCT2026 in Washington, DC
✈️ Travel & accommodation covered
🎓 Registration waived
🤝 Mentorship, masterclasses & networking
⏳ Apply by October 8 here: https://t.co/0jwkfDEEil
#LMIC#ClinicalTrials
Generative AI & Autonomous Systems. Can we evaluate the unevaluable?
At #CVCT2026, experts will discuss whether existing frameworks can truly assess Generative AI in clinical medicine, or whether we need to build new ones.
Join us: https://t.co/VVtCNeZaZk
#CVCT#AI